Prime Medicine Inc banner
P

Prime Medicine Inc
NASDAQ:PRME

Watchlist Manager
Prime Medicine Inc
NASDAQ:PRME
Watchlist
Price: 3.775 USD -2.96%
Market Cap: $681.6m

During the last 3 months Prime Medicine Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 6% over this period (open performance analysis).

The last transaction was made on Aug 1, 2025 by Alphabet Inc. , who bought 5m USD worth of PRME shares.

Last Transactions:
Alphabet Inc.
$+5m
Crandell Keith
$+10m
Nelsen Robert
$+10m
Arch Venture Fund Xii, L.p.
$+10m
Liu David R.
$+52.8k
Liu David R.
$+45.4k
Liu David R.
$+31.2k
Liu David R.
$+33.6k
Lee Ann L.
$+113k
Reine Allan
$+147.2k
Brudnick Richard
$+23.8k
Nelsen Robert
$+20m
Arch Venture Fund Xii, L.p.
$+20m
Crandell Keith
$+20m
Alphabet Inc.
$-284.5k
Alphabet Inc.
$-563.2k
Alphabet Inc.
$-98.1k
Alphabet Inc.
$-994.3k
Alphabet Inc.
$-430.7k
Alphabet Inc.
$-425.1k
Alphabet Inc.
$-240.2k
Alphabet Inc.
$-227k
Alphabet Inc.
$-78.7k
Alphabet Inc.
$-253.9k
Alphabet Inc.
$-510.2k
Alphabet Inc.
$-374.6k
Alphabet Inc.
$-642.2k
Alphabet Inc.
$-227k
Alphabet Inc.
$-230.2k
Alphabet Inc.
$-172.6k
Alphabet Inc.
$-310k
Alphabet Inc.
$-107.9k
View All Transactions

During the last 3 months Prime Medicine Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 6% over this period (open performance analysis).

The last transaction was made on Aug 1, 2025 by Alphabet Inc. , who bought 5m USD worth of PRME shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
4
34.9m USD
9-12
months
4
447k USD

Prime Medicine Inc
Insider Trading Chart

Prime Medicine Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Prime Medicine Inc
Last Insider Transactions

Global
Insiders Monitor

Prime Medicine Inc
Glance View

Prime Medicine Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts. The company went IPO on 2022-10-20. Prime Medicine, Inc. is a United States-based biotechnology company. The firm is engaged in multiple drug discovery programs that target liver, eye, ex-vivo hematopoietic stem cell and neuro-muscular indications. The firm's Prime Editing, a transformative technology that addressed the cause of genetic disease. The firm's collaborative approach help fight disease and accelerating the development of Prime Editing to deliver therapies for patients. Its Prime Editing is used to modify gene-regulatory sequences. These edits can be made in therapeutically relevant cells and organs, including specialized terminally differentiated cells. Its Prime Editing acts as a Deoxyribonucleic acid (DNA) word processor, with the power to search and replace genetic sequences at their exact location in the genome, all without making double-strand breaks in DNA.

PRME Intrinsic Value
LOCKED
Unlock

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett